Science & Medicine
PD-L1 IHC Blueprint Project: Ongoing Progress Toward Consistency Among Assays
By Fred R. Hirsch, MD, PhD
Immunotherapy is a very encouraging development in the treatment of patients with lung cancer. At this phase of its refinement,...
Advocacy & Survivorship
The Lung Cancer Research Foundation and Free to Breathe Merge to...
Effective September 30, 2017, the Lung Cancer Research Foundation and Free to Breathe have merged organizations, with the goal of closing the funding gap...
Meeting News
2017 Lung Cancer SPORE Workshop
By Roy S. Herbst, MD, PhD
The National Cancer Institute’s (NCI’s) Lung Cancer Specialized Programs of Research Excellence (SPORE) and their affiliates met June 21-22,...
